Transgenic nonhuman mammal representing the pathologic...

Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C800S008000, C800S009000, C800S013000, C800S014000

Reexamination Certificate

active

07745690

ABSTRACT:
It is intended to provide a transgenic nonhuman mammal well representing the pathologic conditions of human rheumatoid arthritis. A transgenic nonhuman mammal is obtained by transferring a foreign DNA, wherein a DNA selected from the group consisting of an MHC class II transcriptional activator gene, the activity domain of an MHC class II transcriptional activator gene and a variant of an MHC class II transcriptional activator gene is provided under the control of a type II collagen promoter, into a cell at the early stage of development.

REFERENCES:
patent: WO98/15626 (1998-04-01), None
Kappel et al (1992) Current Opinion in Biotechnology 3, 548-553.
Mullins et al (1993) Hypertension 22, p. 630-633.
Houdebine (1994) J. Biotech. 34, p. 269-287.
Mullins et al. (J. Clin. Invest.1996; 98, p. 1557-1560.
Cameron (1997) Molec. Biol. 7, p. 253-265.
Sigmund (2000) Arteroscler. Throm. Vasc. Biol. 20, p. 1425-1429.
Niemann (1998) Transg. Res. 7, p. 73-75.
Moreadith et al., J. Mol. Med., 1997, p. 208-216.
Pera et al. [Journal of Cell Science 113: 5-10 (2000)].
Wall (1996) Theriogenology 45, 57-68.
Osaki et al. (Biochemical Journal. Sep. 11, 2002; 1-34).
Lindqvist et al. (Trends in Genetics. 2002; S7-S13).
Otten et al. (Journal of Immunology. 2003; 170: 1150-1157).
Harton et al. (Molecular and Cellular Biology, Sep. 2000; 20(17):6185-6194).
(Kanazawa et al. PNAS, Sep. 26, 2006; 103(39): 14465-14470).
Reith et al. (Annual Review Immunology. 2001; 19: 331-3373).
Kanazawa et al. (International Immunology. 2001; 13(7): 951-958).
LeibundGut-Landmann et al. (Eur. J. Immunol. 2004; 34:1513-1525).
Ting et al. (Cell Aptil 2002;S21-S33).
M. Feldmann; “Pathogenesis of arthritis: recent research progress;”Nature Immunology; vol. 2; No. 9; Sep. 2001; pp. 771-773/Discussed in the specification.
P. H. Wooley, et al; “Type II Collagen-Induced Arthritis in Mice;”J. Exp. Med.; vol. 154; Sep. 1981; pp. 688-700./Discussed in the specification.
H. Kim, et al; “Thyrotropin-Mediated Repression of Class IITrans-Activator Expression in Thyroid Cells: Involvement of STAT3 and Suppressor of Cytokine Signaling;”The Journal of Immunology; vol. 171; No. 2; 2003; pp. 616-627.
A. N. Santos, et al.; “Constitutive expression of HLA class II mRNA in synovial fibroblast-like cells from patients with rheumatoid arthritis;”Immunology Letters; vol. 58; No. 1; 1997; pp. 53-58.
A. N. Santos, et al.; “Regulation by transforming growth factor-β1 of class II mRNA and protein expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis;”International Immunology; vol. 10; No. 5;1998; pp. 601-607.
V. Lefebvre, et al.; “An 18-Base-Pair Sequence in the Mouse Proα1(II) Collagen Gene Is Sufficient for Expression in Cartilage and Binds Nuclear Proteins That Are Selectively Expressed in Chondrocytes;”Molecular and Cellular Biology; vol. 16; No. 8; Aug. 1996; pp. 4512-4523.
G. Zhou, et al.; Three High Mobility Group-like Sequences within a 48-Base Pair Enhancer of theCol2a1Gene Are Required for Cartilage-specific Expression in Vivo;The Journal of Biological Chemistry; vol. 273; No. 24; June 12, 1998; pp. 14989-14997.
G. Zhou, et al.; “A 182 bp fragment of the mouse proα1(II) collagen gene is sufficient to direct chonodrocyte expression in transgenic mice;”Journal of Cell Science; vol. 108; No. 12; 1995; pp. 3677-3684.
K. Kakimoto, et al.; Tokushu II Mansei Kansetsu Rheumatism (RA) ni Okeru Saikin no Topics Collagen Yudo Kansetsuen to T-saibo Kogen Juyotai;Clinical Immunology; vol. 26; No. 2; 1994; pp. 171-177 and end sheet (8 Sheets total).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Transgenic nonhuman mammal representing the pathologic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transgenic nonhuman mammal representing the pathologic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic nonhuman mammal representing the pathologic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4179651

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.